Vasopeptides pp 187-196

Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 21) | Cite as

Structure-Activity Relationships of Neurohypophyseal Polypeptides on Different Types of Isolated Mammalian Blood Vessels

  • Burton M. Altura
Chapter

Abstract

Up until the isolation and synthesis of vasopressin in 1953 by du Vigneaud vasopressin was given little serious thought as a useful vasoactive drug because of its well documented coronary constrictor action. Interestingly, however, there is now good evidence to indicate that at least two synthetic neurohypophyseal hormone (NHPH) analogues, namely 2-phenylalanine-8-lysine vasopressin (PLV-2) and 8-ornithine vasopressin, may have significant antiarrhythmic properties in man (see references in 9). Additional experimental studies indicate that at least one of these NHPH analogues, namely PLV-2 (the only one so far investigated in animal coronary circulation), increases the relative myocardial blood flow in rats (16) and relaxes a variety of isolated bovine coronary arteries (1). Furthermore, it has been demonstrated that when PLV-2 was used as a local vasoconstrictor in skin flaps it did not produce any decrease in tissue oxygen tensions, while epinephrine did (20). Possibly more importantly, our laboratory found that PLV-2 improved survival in animals subjected to various forms of shock (9, 10, 11, 13, 19) and suggested this might be due to its unusual microcirculatory effects as observed by direct in-vivo microscopy (4, 7–12, 19). In view of such findings we initiated systematic pharmacologic and structure-activity studies of the NHPH, and particularly their synthetic analogues, not only at the microcirculatory level but on various types of isolated mammalian blood vessels since the latter would be divorced from any in-vivo effects of metabolism and blood flow.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    B.M. Altura, “Differential actions of polypeptides and other drugs on coronary inflow vessels,” Am. Heart J., 72: 709–711, 1966PubMedCrossRefGoogle Scholar
  2. 2.
    B.M. Altura, “Significance of amino acid residues in vasopressin on contraction in vascular muscle,” Am. J. Physiol., 219: 222–229, 1970.PubMedGoogle Scholar
  3. 3.
    B.M. Altura, “Influence of magnesium and cysteine on vasopressininduced contractions in various canine blood vessels, ”Experientia, 26: 1089–1090, 1970.Google Scholar
  4. 4.
    B.M. Altura, “Pharmacology of neurohypophyseal hormones and analogs on isolated vascular muscle and in the terminal vascular bed,” in: J.A. Bevan, R.F. Furchgott, R.A. Maxwell and A.P. Somlyo, Eds., Physiology and Pharmacology of Vascular Neuroeffector Systems. Basel, Karger, pp. 274–290, 1971.Google Scholar
  5. 5.
    B.M. Altura and B.T. Altura, “Heterogeneity of drug receptors in different segments of rabbit thoracic aorta,” European J. Pharmacology 12: 44–52, 1970.Google Scholar
  6. 6.
    B.M. Altura and B.T. Altura, “Differential effects of substrate depletion on drug-induced contractions of rabbit aorta,” Am. J. Physiol., 219: 1698–1705, 1970.PubMedGoogle Scholar
  7. 7.
    B.M. Altura and S.G. Hershey, “Pharmacology of neurohypophyseal hormones and their synthetic analogues in the terminal vascular bed. Structure-activity relationships,” Angiology, 18: 428–439, 1967.PubMedCrossRefGoogle Scholar
  8. 8.
    B.M. Altura and S.G. Hershey, “Structure-activity relationships of neurohypophyseal polypeptides in the microcirculation: A molecular basis for shock therapy,” in: B. Schildt and L. Thoren, Eds., Intermedes Proceedings 1968: Combined Injuries and Shock. Stockholm, Almqvist and Wiksell, pp. 247–259, 1968.Google Scholar
  9. 9.
    B.M. Altura and S.G. Hershey, “A structure-activity basis for vaso-tropic peptide therapy in shock,” in: These Proceedings.Google Scholar
  10. 10.
    B.M. Altura, S.G. Hershey and B.T. Altura, “Microcirculatory actions of polypeptides and their use in the treatment of experimental shock,” Adv. Exptl. Med. Biol., 8: 239–247, 1970.Google Scholar
  11. 11.
    B.M. Altura, S.G. Hershey and V.D.B. Mazzia,“ Microcirculatory approach to vasopressor therapy in intestinal ischemic (SMA) shock,” Am. J. Surgery, 111: 186–192, 1966.CrossRefGoogle Scholar
  12. 12.
    B.M. Altura, S.G. Hershey and B.W. Zweifach, “Effects of a synthetic analogue of vasopressin on vascular smooth muscle,” Proc. Soc. Exptl.{B~iol. Med., 119: 258}261, 1965.Google Scholar
  13. .M. Altura, R. Hsu, V.D.B. Mazzia and S.G. Hershey, “Influence of vasopressors on survival after traumatic, intestinal ischemia and endotoxin shock in rats,” Proc. Soc. Exptl. Biol. Med., 119: 389–393, 1965.Google Scholar
  14. 14.
    B.M. Altura, D. Malaviya and L.R. Orkin, “Comparative contractile effects of vasoactive substances on isolated human umbilical arteries and veins,” Federation Proc., 30: 383, 1971.Google Scholar
  15. 15.
    B.M. Altura, D. Malaviya, C.F. Reich and L.R. Orkin, “Effects of vasoactive agents on isolated human umbilical arteries and veins,” Am. J. Physiol., 222, 1972 (in press).Google Scholar
  16. 16.
    B. Berde, “Some observations on the circulatory effects of oxytocin, vasopressin and similar polypeptides,” in: J.H.M. Pinkerton, Ed., Advances in Oxytocin Research. London, Pergamon Press, pp. 1135, 1965.Google Scholar
  17. 17.
    B. Berde and R.A. Boissonnas, “Basic pharmacological properties of synthetic analogues and homologues of the neurohypophysial hormones,” in: B. Berde, Ed., Handbook of Experimental Pharmacology, vol. 23: Neurohypophysial Hormones and Similar Polypeptides. Berlin, Springer-Verlag, pp. 802–870, 1968.Google Scholar
  18. 18.
    R.A. Boissonnas, “The chemistry of oxytocin and vasopressin,” in: M. Schachter, Ed., Polypeptides which Affect Smooth Muscles and Blood Vessels. London, Pergamon Press, pp. 7–19, 1960.Google Scholar
  19. 19.
    S.G. Hershey, V.D.B. Mazzia, B.M. Altura and L. Gyure, “Effects of vasopressors on the microcirculation and on survival in hemorrhagic shock,” Anesthesiology, 26: 179–189, 1965.PubMedCrossRefGoogle Scholar
  20. 20.
    P. Klingenström, B. Nylen and L. Westermark, “A clinical comparison between adrenaline and octapressin as vasoconstrictors in local anesthesia.” Acta Anaesth. Scand., 11: 35–42, 1967.Google Scholar
  21. 21.
    K. Saameli, “The circulatory actions of the neurohypophysial hormones and similar polypeptides,” in: B. Berde, Ed., Handbook of Experimental Pharmacology, vol. 23: Neurohypophysial Hormones and Similar Polypeptides. Berline, Springer-Verlag, pp. 545–612, 1968.Google Scholar
  22. 22.
    A.V. Somlyo, C. Woo and A.P. Somlyo, “Effects of magnesium on posterior pituitary hormone action on vascular smooth muscle,” Am. J. Physiol., 210: 705–714, 1966.PubMedGoogle Scholar
  23. 23.
    E. Stürmer, “Bioassay precedures for neurohypophysial hormones and similar polypeptides,” in: B. Berde, Ed., Handbook of Experimental Pharmacology, vol. 23: Neurohypophysial Hormones and Similar Polypeptides. Berlin, Springer-Verlag, pp. 130–189, 1968.Google Scholar

Copyright information

© Plenum Press, New York 1972

Authors and Affiliations

  • Burton M. Altura
    • 1
  1. 1.Departments of Anesthesiology and PhysiologyAlbert Einstein College of MedicineBronxUSA

Personalised recommendations